Entecavir demonstrates superior histologic and virologic efficacy over lamivudine in nucleoside-naive HBeAg(-) chronic hepatitis B: results of phase III trial ETV-027 - Shouval,D.; Lai,C-L.; Cheinquer,H. (Hepatology, 2004)